Radek is a member of Evidera’s executive leadership team and the Vice President and Global Head of Peri- and Post-Approval Studies – a global team of scientists and research operations professionals responsible for planning and executing Evidera’s real-world evidence (RWE) and interventional studies. This includes the responsibility for setting the vision and strategy for the group as well as delivering on the group’s financial targets. Prior to this role, Radek served as General Manager of the RWE and Meta Research practice areas within Evidera, focused on generating and synthesizing real-world and clinical evidence. He also formerly held the position of EU Director, with operational and business responsibilities for the growth of European service offerings.
Before joining Evidera, Radek was a research scientist at the Liberty Mutual Research Institute for Safety, where he developed an extensive expertise with multi-level claim and secondary databases as well as with different aspects of research project quality review. His research also included several literature reviews of health and productivity of the workforce. Radek has presented at numerous conferences, including the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), and his work has been published in multiple scientific journals. Radek holds a PhD and an MA in economics from the University of Connecticut, as well as an MSc in finance and banking from the University of Economics, Poznan, Poland. He has held adjunct appointments at Trinity College (USA) and the Harvard School of Public Health.